EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FGF9 Recruits β‐Catenin to Increase Hepatic ECM Synthesis and Promote NASH‐Driven HCC

Lei Zhang, Qing Zhang, Da Teng, Manyu Guo, Kechao Tang, Zhenglin Wang, Xiang Wei, Li Lin, Xiaomin Zhang, Xiuyun Wang, Dake Huang, Cuiping Ren und 6 weitere

Advanced Science · 2023

DOI: 10.1002/advs.202301166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Lei Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Metabolic Disease Research Center, School of Basic Medicine, Anhui Medical University, 230032, Hefe…. Hauptthemen laut MEDLINE: beta Catenin, Carcinoma, Hepatocellular, Disease Models, Animal, Extracellular Matrix. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Key Research and Development Program of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most nonalcoholic steatohepatitis (NASH) patients develop severe fibrosis through extracellular matrix (ECM) accumulation, which can lead to hepatocellular carcinoma (HCC). Fibroblast growth factor 9 (FGF9) is involved in serial types of cancer; however, the specific role of FGF9 in NASH‐driven HCC is not fully understood. This study finds that FGF9 is increased in patients with NASH‐associated HCC. Furthermore, NASH‐driven HCC mice models by feeding wildtype mice with high‐fat/high‐cholesterol (HFHC) diet and low dose carbon tetrachloride (CCl 4 ) treatment is established; and identified that hepatic FGF9 is increased; with severe fibrosis. Additionally, AAV‐mediated knockdown of FGF9 reduced the hepatic tumor burden of NASH‐driven HCC mice models. Hepatocyte‐specific FGF9 transgenic mice (FGF9 Alb ) fed with a HFHC diet without CCl 4 treatment exhibited an increased hepatic ECM and tumor burden. However, XAV‐939 treatment blocked ECM accumulation and NASH‐driven HCC in FGF9 Alb mice fed with HFHC diet. Molecular mechanism studies show that FGF9 stimulated the expression of ECM related genes in a β‐catenin dependent manner; and FGF9 exerts its effect on β‐catenin stability via the ERK1/2‐GSK‐3β signaling pathway. In summary, the data provides evidence for the critical role of FGF9 in NASH‐driven HCC pathogenesis; wherein it promotes the tumors formation through the ECM pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninCarcinoma, HepatocellularDisease Models, AnimalExtracellular MatrixFibroblast Growth Factor 9Liver NeoplasmsNon-alcoholic Fatty Liver DiseaseAnimalsHumansMaleMiceMice, Inbred C57BLMice, Transgenic

Stichwörter der Autor:innen

FGF9NASHextracellular matrixliver cancerβ-catenin

Substanzen

beta CateninFGF9 protein, humanFgf9 protein, mouseFibroblast Growth Factor 9

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Metabolic Disease Research Center, School of Basic Medicine, Anhui Medical University, 230032, Hefei, China.
  • Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key of Cellular Homeostasis and Disease, Department of Physiology and Pathophysiology, Tianjin Medical University, 300070, Tianjin,…
  • Department of Hepatopancreatobiliary Surgery, Affifiliated Chuzhou Hospital of Anhui Medical University (The First People's Hospital of Chuzhou), Chuzhou, 239001, China.
  • Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, China.
  • Synthetic Laboratory of School of Basic Medicine Sciences, Anhui Medical University, 230032, Hefei, China.
  • Department of Microbiology and Parasitology, School of Basic Medicine, Anhui Medical University, 230032, Hefei, China.

ORCID-Profile: Huabing Zhang

Förderung

  • Anhui Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • Key Research and Development Program of Anhui Province
  • Clinical medical research transformation project of Anhui Province
  • Research Fund of Anhui Institute of translational medicine

Zitieren

APA

Zhang, L., Zhang, Q., Teng, D., Guo, M., Tang, K., Wang, Z., Wei, X., Lin, L., Zhang, X., Wang, X., Huang, D., Ren, C., Yang, Q., Zhang, W., Gao, Y., Chen, W., Chang, Y., & Zhang, H. (2023). FGF9 Recruits β‐Catenin to Increase Hepatic ECM Synthesis and Promote NASH‐Driven HCC. Advanced Science. https://doi.org/10.1002/advs.202301166

Vancouver

Zhang L, Zhang Q, Teng D, Guo M, Tang K, Wang Z, et al. FGF9 Recruits β‐Catenin to Increase Hepatic ECM Synthesis and Promote NASH‐Driven HCC. Advanced Science. 2023. doi:10.1002/advs.202301166

BibTeX
@article{Zhang2023,
  author = {Zhang, Lei and Zhang, Qing and Teng, Da and Guo, Manyu and Tang, Kechao and Wang, Zhenglin and Wei, Xiang and Lin, Li and Zhang, Xiaomin and Wang, Xiuyun and Huang, Dake and Ren, Cuiping and Yang, Qingsong and Zhang, Wenjun and Gao, Yong and Chen, Wei and Chang, Yongsheng and Zhang, Huabing},
  title = {FGF9 Recruits β‐Catenin to Increase Hepatic ECM Synthesis and Promote NASH‐Driven HCC},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202301166}
}
Kostenlos starten →